FILORGA,the 1st French aesthetic medicine laboratory founded in 1978, originallydesigned, developed and produced injectable products that were used by leadingmedical specialists all over the world.


In 2007,the brand made its expertise in aesthetic medicine available to the generalpublic upon the creation of MEDI-COSMETIQUE, a range of revolutionaryanti-ageing products formulated with NCEF, a unique compound encapsulating theactive ingredients used in injections.


Morethan fifty cosmetic products have become available over time, all of whichshare the same principle: to combine optimal and clinically proveneffectiveness visible in 7 days* with sensorial textures and premium packaging.


FILORGAis today present in more than 70 countries throughout the world…


* Testedon all FILORGA day creams (except PIGMENT-WHITE, anti-dark spot effectivenessvisible in 15 days).





MichelTordjman, a French doctor of aesthetic medicine and enthusiastic cellularbiologist, began research on skin ageing that led him to focus on cellularrejuvenation through mesotherapy. Long before the phenomenal success of botox,he developed injectable products with hyaluronic acid for use by the medicalprofession and created NCTF, a revitalising anti-ageing solution that acts onthe 6 key parameters of skin quality: hydration, wrinkles, firmness, radiance,evenness and pores. Initially used by medical staff in anti-ageing mesotherapyinjections, NCTF later gave way to NCEF, the encapsulated compound used in thecosmetic range for profound skin penetration.




LaboratoiresFilorga launched GLYKOPEEL, a range of anti-ageing glycolic acid peels for useby doctors to rejuvenate the skin and improve its condition.




LaboratoiresFilorga launched their MEDI-COSMETIQUE cosmetic range for the general public,directly inspired by aesthetic medicine. Products launched at the time,including Optim-eyes and Meso-Mask*, became iconic best-sellers.


* At FILORGA,2018 World sell-in data.




Theaesthetic medicine branch of Laboratoires Filorga launched X-HA3. The range ofinjectable products was enlarged with X-HA Volume (to combat deep lines andrestore volume) and MHA18 (superficial lines) in 2010.




Renewalof the range of peels with the introduction of TIME PEEL, BRIGHT PEEL and LIGHTPEEL, the 1st made-to-measure superficial peels with gluconolactone forenhanced tolerance, even on sensitive skin.




Theaesthetic medicine branch of Laboratoires Filorga, where the ART-FILLER rangewas developed, created and inaugurated one of the few global production unitscapable of producing injectable hyaluronic acid-based products, a newgeneration of fillers comprised of 4 injectable products to be used byaesthetic doctors as an adaptable method to fill wrinkles.




Filorga’sMEDI-COSMETIQUE range became the leading anti-ageing range in pharmacies andparapharmacies in France*


*Source: IQVIA – Pharmatrend/Paratrend PharmaOne – Facial anti-ageing andanti-wrinkle market in pharmacies and parapharmacies in France – 2017 and 2018– In figures.




Filorga’saesthetic medicine branch became FILL MED.


Note :Product with *NCTF ingredients which packing text are gradually changed asNCEF.